| 英文名称 |
中文名称 |
CAS号 |
操作 |
| KNK437 |
KNK437 |
218924-25-5 |
详细
|
| K-Ras(G12C) inhibitor 9 |
K-Ras(G12C) inhibitor 9 |
1469337-91-4 |
详细
|
| KU-60019 |
KU-60019 |
925701-49-1 |
详细
|
| KW-2449 HCl |
[4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮 |
1000669-72-6 |
详细
|
| L-67 |
|
325970-71-6 |
详细
|
| LAQ824 |
达诺司他 |
404951-53-7 |
详细
|
| Laropiprant(MK-0524) |
LAROPIPRANT |
571170-77-9 |
详细
|
| LDN193189 HCl |
LDN-193189 HCl |
1062368-62-0 |
详细
|
| LJH685 |
2,6-二氟-4-[4-[4-(4-甲基-1-哌嗪基)苯基]-3-吡啶基]苯酚 |
1627710-50-2 |
详细
|
| LJI-308 |
LJI308 |
1627709-94-7 |
详细
|
| LLY-507 |
LLY-507 |
1793053-37-8 |
详细
|
| Lomeguatrib (PaTrin-2) |
罗米鲁曲 |
192441-08-0 |
详细
|
| Losartan Carboxylic Acid |
氯沙坦羧酸 |
124750-92-1 |
详细
|
| LRRK2-IN-1 |
5,11-二氢-2-[[2-甲氧基-4-[[4-(4-甲基-1-哌嗪基)-1-哌啶基]羰基]苯基]氨基]-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮 |
1234480-84-2 |
详细
|
| LSN2814617 |
LSN2814617消旋体 |
1313498-08-6 |
详细
|
| LY2157299 |
LY 2157299 |
700874-72-2 |
详细
|
| LY2608204 |
(1R,2S)-2-环己基-1-[4-(环丙基磺酰基)苯基]-N-[5-[[2-(1-吡咯烷基)乙基]硫代]-2-噻唑基]环丙烷甲酰胺 |
1234703-40-2 |
详细
|
| LY2835219(Abemaciclib) |
阿贝西利 |
1231929-97-7 |
详细
|
| LY2886721 |
N-[3-[(4AS,7AS)-2-氨基-4A,5-二氢-4H-呋喃并[3,4-D][1,3]噻嗪-7A(7H)-基]-4-氟苯基]-5-氟-2-吡啶甲酰胺 |
1262036-50-9 |
详细
|
| LY310762 |
LY310762 |
192927-92-7 |
详细
|
| LY-411575 |
(AS)-N-[(1S)-2-[[(7S)-6,7-二氢-5-甲基-6-氧代-5H-二苯并[B,D]氮杂卓-7-基]氨基]-1-甲基-2-氧代乙基]-3,5-二氟-ALPHA-羟基苯乙酰胺 |
209984-57-6 |
详细
|
| Maraviroc (UK427857) |
马拉维若 |
376348-65-1 |
详细
|
| Mavatrep(JNJ-39439335) |
CS-1660 |
956274-94-5 |
详细
|
| MCC950 sodium |
N-[[(1,2,3,5,6,7-六氢-S-引达省-4-基)氨基]羰基]-4-(1-羟基-1-甲基乙基)-2-呋喃磺酰胺单钠盐 |
256373-96-3 |
详细
|
| MHY1485 |
MHY1485 |
326914-06-1 |
详细
|
| MI-2(Menin-MLL Inhibitor) |
2-氯-N-[4-[5-(3,4-二氯苯基)-3-(2-甲氧基乙氧基)-1H-1,2,4-三唑-1-基]苯基]乙酰胺 |
1047953-91-2 |
详细
|
| MI-3 (Menin-MLL Inhibitor) |
MI-3 (Menin-MLL Inhibitor) |
1271738-59-0 |
详细
|
| MK-0941 |
MK-0941 |
1137916-97-2 |
详细
|
| MK-2206 2HCl |
MK-2206 2HCl |
1032350-13-2 |
详细
|
| MK-571 |
MK-571 SODIUM HYDRATE |
115103-85-0 |
详细
|
| MK-8776 (SCH 900776) |
6-溴-3-(1-甲基-1H-吡唑-4-基)-5-(3R)-3-哌啶基吡唑并[1,5-A]嘧啶-7-胺 |
891494-63-6 |
详细
|
| ML-098 |
CS-1456 |
878978-76-8 |
详细
|
| ML-224 |
CS-1585 |
1338824-21-7 |
详细
|
| ML-241 |
ML241 |
1346528-06-0 |
详细
|
| ML-277 |
ML-277 |
1401242-74-7 |
详细
|
| ML347 |
(ML347) |
1062368-49-3 |
详细
|
| ML365 |
ML-365 |
947914-18-3 |
详细
|
| ML-7 HCl |
1-(5-碘萘-1-磺酰基)-1H-六氢-1,4-二氮杂卓盐酸盐 |
110448-33-4 |
详细
|
| MN-64 |
MN 64 |
92831-11-3 |
详细
|
| Moclobemide |
吗氯贝胺 |
71320-77-9 |
详细
|
| Molidustat(BAY 85-3934) |
MOLIDUSTAT |
1154028-82-6 |
详细
|
| Motolimod (VTX-2337) |
MOTOLIMOD |
926927-61-9 |
详细
|
| MPEP hydrochloride |
2-甲基-6-(苯基乙炔基)吡啶盐酸盐 |
219911-35-0 |
详细
|
| MPI-0479605 |
N6-环己基-N2-(2-甲基-4-吗啉苯基)-9H-嘌呤-2,6-二胺 |
1246529-32-7 |
详细
|
| MS023 |
N1-甲基-N1-[[4-[4-(异丙氧基)苯基]-1H-吡咯-3-基]甲基]-1,2-乙二胺 |
1831110-54-3 |
详细
|
| MSX 122 |
MSX 122 |
897657-95-3 |
详细
|
| Naloxegol Oxalate(NKTR-118) |
聚乙二醇纳诺醇 |
1354744-91-4 |
详细
|
| Napabucasin (BBI608) |
2-乙酰基呋喃并-1,4-萘醌 |
83280-65-3 |
详细
|
| Nepicastat HCl |
盐酸内匹司他 |
170151-24-3 |
详细
|
| NG 52 (Compound 52 ) |
2-[[6-[(3-氯苯基)氨基]-9-异丙基-9H-嘌呤-2-基]氨基]乙醇 |
212779-48-1 |
详细
|
| NIBR189 |
NIBR189 |
1599432-08-2 |
详细
|
| NS 9283 |
NS 9283 |
913830-15-6 |
详细
|
| NS-398 |
抑制剂 |
123653-11-2 |
详细
|
| NS6180 |
NS-6180 |
353262-04-1 |
详细
|
| NSC348884 |
N1,N1,N2,N2-四[(6-甲基-1H-苯并咪唑-2-基)甲基]-1,2-乙二胺 |
81624-55-7 |
详细
|
| NSC-41589 |
化合物NSC-41589 |
6310-41-4 |
详细
|
| NSC59984 |
1-(4-甲基-1-哌嗪基)-3-(5-硝基-2-呋喃基)-2-丙烯-1-酮 |
803647-40-7 |
详细
|
| nu7026 |
2-(4-吗啉基)-4H-萘并[1,2-B]吡喃-4-酮 |
154447-35-5 |
详细
|
| NVP-ACC-789 |
N-(3-溴-4-甲基苯基)-4-(4-吡啶甲基)-1-酞嗪胺 |
300842-64-2 |
详细
|
| NVP-TAE684 |
NVP-TAE684 |
761439-42-3 |
详细
|
| OAC1 |
N-1H-吡咯并[2,3-C]吡啶-5-基苯甲酰胺 |
300586-90-7 |
详细
|
| OAC2 |
OAC2 |
6019-39-2 |
详细
|
| OF-1 |
OF-1 |
919973-83-4 |
详细
|
| ON123300 |
8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 |
1357470-29-1 |
详细
|
| ONX-0912(Oprozomib) |
ONX0912 |
935888-69-0 |
详细
|
| PAC-1 |
PAC1 |
315183-21-2 |
详细
|
| Palbociclib isethionate |
帕布昔利布羟乙基磺酸盐 |
827022-33-3 |
详细
|
| Pardoprunox.HCl(SLV-308) |
盐酸帕多芦诺 |
269718-83-4 |
详细
|
| PBIT |
2 - (4 - Methylphenyl) - 1,2 - benzisothiazol - 3(2H)-one |
2514-30-9 |
详细
|
| PBTZ169 |
PBTZ169 |
1377239-83-2 |
详细
|
| PD 153035(AG-1517) |
4-[(3-溴苯基)氨基]-6,7-二甲氧基喹啉 |
153436-54-5 |
详细
|
| PD153035 HCl |
PD153035 HCl |
183322-45-4 |
详细
|
| PD168393 |
PD168393 |
194423-15-9 |
详细
|
| Pelitinib (EKB-569) |
培利替尼 |
257933-82-7 |
详细
|
| Perifosine |
哌立福辛 |
157716-52-4 |
详细
|
| PF-03394197 |
奥拉替尼 |
1208319-26-9 |
详细
|
| PF-04418948 |
PF04418948 |
1078166-57-0 |
详细
|
| PF-CBP1(PF-06670910) HCl |
|
|
详细
|
| PFI-4 |
N-(1,3-二甲基-2-氧代-6-(吡咯烷-1-基)-2,3-二氢-1H-苯并[D]咪唑-5-基)-2-甲氧基苯甲酰胺 |
900305-37-5 |
详细
|
| PI3K-IN-2 |
PI3K/MTOR抑制剂 |
1225037-39-7 |
详细
|
| Pilaralisib (XL-147) |
2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺 |
934526-89-3 |
详细
|
| Pimavanserin(ACP-103) |
匹莫范色林 |
706779-91-1 |
详细
|
| Pirodavir (R 77975) |
吡罗达韦 |
124436-59-5 |
详细
|
| PP2 |
PP2 |
172889-27-9 |
详细
|
| PP3 |
4-氨基-1-苯基吡唑[3,4-D]嘧啶 |
5334-30-5 |
详细
|
| PRT4165(NSC-600157) |
PRT4165 |
31083-55-3 |
详细
|
| PTACH (NCH-51) |
NCH-51 |
848354-66-5 |
详细
|
| PYR-41 |
PYR 41 |
418805-02-4 |
详细
|
| Pyridostatin(RR 82) trifluoroacetate |
4-(2-氨基乙氧基)-N2,N6-二[4-(2-氨基乙氧基)-2-喹啉基]-2,6-吡啶二甲酰胺 |
1085412-37-8 |
详细
|
| QNZ |
N4-[2-(4-苯氧基苯基)乙基]-4,6-喹唑啉二胺 |
545380-34-5 |
详细
|
| Quisinostat (JNJ-26481585) 2HCl |
JNJ 26854165 |
875320-29-9 |
详细
|
| R-428 |
R428 |
1037624-75-1 |
详细
|
| Remodelin |
REMODELIN |
949912-58-7 |
详细
|
| Resiquimod |
雷西莫特 |
144875-48-9 |
详细
|
| RGFP966 |
RGFP966 |
1357389-11-7 |
详细
|
| RI-2 |
化合物RI-2 |
1417162-36-7 |
详细
|
| Ritalin (Methylphenidate Hcl) |
盐酸哌甲酯 |
298-59-9 |
详细
|
| Lorediplon |
LOREDIPLON |
917393-39-6 |
详细
|
| OTS-964 |
OTS964 |
1338545-07-5 |
详细
|
| PD-1/PD-L1 inhibitor 1 |
PD-1 |
1675201-83-8 |
详细
|